Signup Crypto ETF Stocks News

Life's A Game--And the Buckeyes Are Out to Win It on Destination: Scientology, Columbus

LOS ANGELES, June 16, 2025 /PRNewswire/ -- Scientology Network's DESTINATION: SCIENTOLOGY, the weekly travelogue series that takes viewers inside Scientology Churches all around the world and discovers what makes each one unique, presents an episode featuring Columbus, Ohio, premiering on June ...

Source: www.benzinga.com
June 16, 2025 | 22:34:00
Category: General

ANAVEX SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Anavex Life Sciences Corp. ( NASDAQ: AVXL ) and Encourages Long-Term Investors to Contact the Firm - Anavex Life Sciences ( NASDAQ:AVXL )

PHILADELPHIA, June 16, 2025 ( GLOBE NEWSWIRE ) -- The law firm of Kaskela Law LLC announces that it is investigating potential breach of fiduciary duty claims concerning Anavex Life Sciences Corp. AVXL ( "Anavex" ) on behalf of the company's long-term shareholders.

Source: www.benzinga.com
June 16, 2025 | 22:38:45
Category: News

Enzo Biochem Reports Third Quarter Fiscal Year 2025 Results

FARMINGDALE, N.Y., June 16, 2025 ( GLOBE NEWSWIRE ) -- Enzo Biochem, Inc. ( OTCQX: ENZB ) ( "Enzo" or the "Company" ) today announced financial results for the fiscal third quarter ended April 30, 2025.

Source: www.globenewswire.com
June 16, 2025 | 22:40:00
Category: News

Bird and Spin Launch AI-Powered Rider Score to Improve Safety and Compliance

Atlanta/Denver, June 16, 2025 ( GLOBE NEWSWIRE ) -- Bird and Spin, both operated by Third Lane Mobility, today announced the rollout of a new AI-powered feature called Rider Score, designed to improve how shared e-scooters and e-bikes are used in cities around the world.

Source: www.benzinga.com
June 16, 2025 | 22:41:57
Category: General

If You Invested $1000 In This Stock 15 Years Ago, You Would Have This Much Today - Roper Technologies ( NASDAQ:ROP )

Roper Technologies ROP has outperformed the market over the past 15 years by 4.22% on an annualized basis producing an average annual return of 16.26%. Currently, Roper Technologies has a market capitalization of $60.74 billion.

Source: www.benzinga.com
June 16, 2025 | 22:45:15
Category: Trading

Aura Minerals Inc. Announces Results of 2025 Annual General Meeting of Shareholders

ROAD TOWN, British Virgin Islands, June 16, 2025 ( GLOBE NEWSWIRE ) -- Aura Minerals Inc. ( TSX: ORA ) ( B3: AURA33 ) ( OTCQX: ORAAF ) ( "Aura" or the "Company" ) , announces the voting results from its Annual General Meeting of Shareholders that was held on June 16, 2025, via live webcast.

Source: www.globenewswire.com
June 16, 2025 | 23:02:00
Category: News

Picton Mahoney Asset Management Announces Monthly Distribution for PICTON Long Short Income Alternative Fund Exchange Traded Fund Units, PICTON Credit Opportunities Alternative Fund Exchange Traded Fund Units, PICTON Core Bond Fund Exchange Traded Fund Units, PICTON Multi-Strategy Alpha Alternative Fund Exchange Traded Fund Units and PICTON Investment Grade Alternative Fund Exchange Traded Fund Units

TORONTO, June 16, 2025 /CNW/ - PFIA PFSS PFCB PFAA PFIG Picton Mahoney Asset Management announced today that it has declared the June 2025 monthly cash distribution of $0.0351 per unit for the ETF units ( "ETF Units" ) of the PICTON Long Short Income Alternative Fund ( formerly Picton Mahoney ...

Source: www.benzinga.com
June 16, 2025 | 23:03:00
Category: Markets

Here's How Much You Would Have Made Owning Quest Diagnostics Stock In The Last 5 Years - Quest Diagnostics ( NYSE:DGX )

Quest Diagnostics DGX has outperformed the market over the past 5 years by 299.46% on an annualized basis producing an average annual return of 313.78%. Currently, Quest Diagnostics has a market capitalization of $20.33 billion.

Source: www.benzinga.com
June 16, 2025 | 23:15:16
Category: Trading

PolyPid Secures $26.7 Million Through Warrant Exercise Following Successful SHIELD II Phase 3 Trial Results

PETACH TIKVA, Israel, June 17, 2025 ( GLOBE NEWSWIRE ) -- PolyPid Ltd. ( Nasdaq: PYPD ) ( "PolyPid" or the "Company" ) , a late-stage biopharma company aiming to improve surgical outcomes, today announced that following its recently announced successful SHIELD II phase 3 topline results, it has ...

Source: www.globenewswire.com
June 16, 2025 | 23:20:00
Category: News

PolyPid Secures $26.7 Million Through Warrant Exercise Following Successful SHIELD II Phase 3 Trial Results - PolyPid ( NASDAQ:PYPD )

The Company Anticipates that with this Additional Funding, PolyPid's Runway would be Extended beyond Anticipated U.S. Food and Drug Administration ( "FDA" ) Approval of D-PLEX₁₀₀. The Company Recently Announced Successful Topline Results from its Phase 3 SHIELD II Trial.

Source: www.benzinga.com
June 16, 2025 | 23:20:36
Category: News

© Natavest 2025 - 2026